Key result
NMR-based B.I.LISA correlates strongly with standard lipid assays despite ~4% to ~15% median deviations.
Why the study?
Independent validation of proprietary NMR-based lipoprotein profiling methods is crucial for verifying clinical accuracy and reliability in cardiovascular risk assessment.
Does the 1H NMR-based B.I.LISA method provide comparable quantitative lipoprotein measurements and assess dietary intervention outcomes as accurately as standard enzymatic assays?
Observational (n=164)
Yes
Does the 1H NMR-based B.I.LISA method provide comparable quantitative lipoprotein measurements and assess dietary intervention outcomes as accurately as standard enzymatic assays?
Effect estimate: R = 0.85-0.92
p-value: p=<0.01
NMR-based quantitative lipoprotein profiling demonstrates high correlation with standard enzymatic assays, supporting its utility in high-throughput cardiovascular research and clinical diagnostics, despite minor deviations in high-triglyceride and atypical samples.
No takes yet. Share an insight, caveat, or question.
May support exploratory NMR lipoprotein profiling; leaves open clinical adoption pending deviation resolution.
Zhu et al. (2025) conducted an observational in Prehypertension and Stage 1 Hypertension (n=164). NMR-based B.I.LISA method vs. Standard enzymatic assays was evaluated on Concordance between NMR-based B.I.LISA and standard enzymatic assays for TC, TGs, and HDL-C (R = 0.85-0.92, p=<0.01). The NMR-based B.I.LISA method demonstrated high correlation (R = 0.85–0.92) with standard enzymatic assays for lipoprotein measurement, despite significant median relative deviations of -4% to -15%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: